Article in Cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 1 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
9 authors at 4 institutions in 3 countries.
Min-Yu LanDepartment of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.ORCID 0000-0001-7361-8475
Tsu-Kung LinDepartment of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Baiba LaceRiga East Clinical University Hospital, Latvia Institute of Clinical and Preventive Medicine, University of Latvia, LV-1038 Riga, Latvia.ORCID 0000-0001-5371-6756
Algirdas UtkusDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Birute BurnyteDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Kristina GrigalionieneDepartment of Human and Medical Genetics, Institute of Biomedical Sciences, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.ORCID 0000-0002-1245-4849
Yu-Han LinCenter for Mitochondrial Research and Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.
Inna InashkinaLatvian Biomedical Research and Study Center, LV-1067 Riga, Latvia.
Chia-Wei LiouDepartment of Neurology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 83301, Taiwan.ORCID 0000-0002-9003-4065
Chang Gung University · TWVilnius University · LTLatvian Biomedical Research and Study Centre · LVRiga East University Hospital · LV
Funding
Chang Gung University College of Medicine and Kaohsiung Chang Gung Memorial Hospital CMRPG8L1071-2, CRRPG8K0041-3Ministry of Science and Techinoloogy, Taiwan MOST 104-2923-B-182A-001-MY3, MOST 110-2314-B-182A-132
6 · The paper itself
Abstract
Variants of mitochondrial DNA (mtDNA) have been identified as risk factors for the development of Parkinson's disease (PD). However, the underlying pathogenetic mechanisms remain unclear. Cybrid models carrying various genotypes of mtDNA variants were tested for resistance to PD-simulating MPP
Indexed as
DNA, MitochondrialHaplotypesParkinson DiseaseHumansMitochondriaProtein Phosphatase 1Unfolded Protein ResponseDNA, MitochondrialProtein Phosphatase 1cybridmitochondrial haplogroupParkinson’s diseasetranscriptomeunfolding protein response
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Unraveling the Pathogenetic Mechanisms Underlying the Association between Specific Mitochondrial DNA Haplogroups and Parkinson's Disease. · full record | OpenQuestion